Salindawan, Mohadjera .

HRN: 22-65-95  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2023
AMPICILLIN 500MG (VIAL)
11/10/2023
11/17/2023
IV
350mg
Q 6hrs
Pcap C
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: